| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 75,354 | 58,511 | 33,565 | 19,727 | | Cost of Revenue | 25,063 | (7,086) | 7,086 | 8,452 | | | Gross Profit | 50,291 | 65,597 | 26,479 | 11,275 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (8,888) | 22,989 | 5,125 | 5,783 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 35,246 | 32,691 | 27,529 | 10,516 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 23,933 | 9,917 | (6,175) | (5,024) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (17,966) | (33,992) | 20,222 | (4,789) | | Earnings Before Interest And Taxes | 5,143 | (24,075) | 14,047 | (9,813) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 5,143 | (24,075) | 14,047 | (9,813) | | Income Tax Expense | 7,959 | 4,125 | (85) | 2,881 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,816) | (28,200) | 14,132 | (12,694) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,816) | (28,200) | 14,132 | (12,694) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,816) | ($28,200) | $14,132 | ($12,694) |
|
0.19% Nasdaq 
0.31 (5.15%) 
Income Statement
